All News

Amazon says new prescription service overcomes cost and insurance barriers for patients.

An Independent Data Monitoring Committee recommends stopping 2 phase 3 trials early for efficacy following positive results in November 2022.

In a phase 3 trial, the risk of disease progression, relapse, or death was reduced by 27% with polatuzumab vedotin-piiq plus R-CHP compared with R-CHOP in adults with previously untreated diffuse large B-cell lymphoma or high-grade B-cell lymphoma.

Pharmacists must be involved in managing adverse effects and drug-drug interactions as psychedelic medicines collide with traditional psychiatric treatments.

Data from the aflibercept 8 mg clinical trial program will be presented at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting, April 23 to 27.

Building strong, trusting relationships helps combat hesitancy, creating healthier communities.

Agency updates emergency use authorization for the Moderna and Pfizer-BioNTech COVID-19 vaccinations, which are no longer authorized for used in the United States.

Mosunetuzumab-axgb may be better tolerated by older adults with relapsed or refractory follicular lymphoma and patients with poor performance status.

Atypical respiratory syncytial virus epidemics may continue, and testing patients for multiple respiratory pathogens when indicated might be necessary.

Analysis shows that babies of mothers who used drugs while pregnant were shorter at birth and weighed less during the breastfeeding stage compared with non-drug-exposed infants.

Investigators use a large PCR-only data set to confirm that PCR CT can predict recurrence-free survival, using Cox proportional hazards regression.

Neurovascular mechanisms cause the decrease in BP levels, results from a study of 23 participants in Brazil show.

The findings could inform revisions to safety guidelines and policies that help protect people with cardiovascular issues during heat waves.

Omidubicel-onlv therapy aims to quicken the recovery of neutrophils and reduce the risk of infection in patients with cancer.

Social media can be an excellent tool to provide education and build your own brand, but professionalism and appropriateness are paramount.

The Apothecary Shoppe in Utah knows patients by name, garners new business via word of mouth.

Durvalumab lowered the risk of death by 32% in patients with non-small cell lung cancer compared to chemotherapy alone.

Substantial strides have been made in the management of Ph+ ALL.

The treatment from Keytruda and Merck shows a clinical response of 89% for individuals with unresectable metastatic desmoplastic melanoma.

Findings show that study participants experienced improvements in both blood sugar control and the lipid profile.

Atogepant (Qulipta; AbbVie) is the first and only oral calcitonin gene-related peptide receptor antagonist to gain FDA approval for the prevention of episodic and chronic migraine.

Multicancer early detection test could detect cancer with an AUC of 0.94 for all cancer types and stages.

A new scientific statement from the American Heart Association notes that the process falls short for those who are not white.

The efficacy and tolerability of rizatriptan for acute migraine treatment has been well established.

Although payers have become somewhat accustomed to the high cost of specialty drugs, the price tags for gene therapies are causing “sticker shock.”

According to 5-year follow-up data, the combination of tafasitamab-cxix and lenalidomide produced a durable response in patients with diffuse large B-cell lymphoma.

Other health essentials, such as groceries, prescriptions, some OTC medications, are tax-exempt in many states.

Some classes and curricula can contribute to preexisting stigmas about drugs and treatments for mental health.

The 2 most hypervirulent strains of Clostridioides difficile are associated with the consumption of pork and shellfish.

Respiratory syncytial virus (RSV) vaccine demonstrated efficacy of 66.7% in reducing RSV-associated lower respiratory tract illness with at least 2 signs or symptoms in older adults.